Company news

Voyager Therapeutics, Inc. news in 2023

Voyager Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program

December 5, 2023

Voyager Therapeutics Reports Third Quarter 2023 Financial and Operating Results

November 5, 2023

Voyager Therapeutics Announces Third Quarter 2023 Conference Call and Webcast

October 29, 2023

Voyager Therapeutics Announces Appointment of Beth Shafer as Chief Business Officer

August 6, 2023

Voyager Therapeutics Reports Second Quarter 2023 Financial and Operating Results

August 2, 2023

Voyager Therapeutics Announces Second Quarter 2023 Conference Call and Webcast

July 26, 2023

Voyager Therapeutics Announces Appointment of Jacquelyn Fahey Sandell as Chief Legal Officer

July 9, 2023

Voyager Therapeutics Presents Robust, Multi-Species Results from Preclinical Studies of IV-Delivered, TRACER™-Generated Novel Capsids at the ASGCT 26th Annual Meeting

May 17, 2023

Voyager Therapeutics Reports First Quarter 2023 Financial and Operating Results

May 8, 2023

Voyager Therapeutics Announces Appointment of George Scangos, Ph.D., to Board of Directors

May 8, 2023

Voyager Therapeutics Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting

May 1, 2023

Voyager Therapeutics Announces First Quarter 2023 Conference Call and Webcast

May 1, 2023

Voyager Therapeutics Presents New Data Supporting Tau Antibody Program for Alzheimer’s Disease and GBA1 Gene Therapy Program for Parkinson’s Disease at the AD/PD™ Conference

March 27, 2023

Voyager Therapeutics Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

March 6, 2023

Voyager Therapeutics to Receive $25 Million Payment for License of Next-Generation AAV Capsids for Multiple Neurologic Disease Targets

March 5, 2023

Voyager Therapeutics Announces Fourth Quarter and Full Year 2022 Conference Call and Webcast

February 27, 2023

Calls in 2023